Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Yassine, H. M., Benslimane, F. M., Khatib, H. A. A., . . . Butt, A. A. (2022). Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant. Clinical Infectious Diseases, 75(1), e1188. https://doi.org/10.1093/cid/ciab909
Chicago Style (17th ed.) CitationAbu-Raddad, Laith J., et al. "Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant." Clinical Infectious Diseases 75, no. 1 (2022): e1188. https://doi.org/10.1093/cid/ciab909.
MLA (9th ed.) CitationAbu-Raddad, Laith J., et al. "Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant." Clinical Infectious Diseases, vol. 75, no. 1, 2022, p. e1188, https://doi.org/10.1093/cid/ciab909.